Neurocysticercosis: The duration of its preclinical phase relies on the parasite location
Tropical Medicine & International Health · 2024
DOI: 10.1111/tmi.13964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Medicine & International Health, 2024. Verfasst von Carlos Alejandro Tellez-Arellano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clínica de neurocisticercosis, Instituto Nacional de Neurologia y Neurocirugía Manuel Velasco Suarez, Ciudad de México, Mexico. Hauptthemen laut MEDLINE: Neurocysticercosis, Parasites, Taenia solium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
Neurocysticercosis (NC) is a heterogeneous disease particularly in terms of response to treatment and prognosis. Parasite localization is one of the main factors involved in this heterogeneity. In this study we aim to determine whether differences in the duration of the preclinical phase associated with parasite location, could contribute to said heterogeneity.
Methods
Ninety‐nine patients were included, 24 with parasites in the parenchyma (PAR), 56 in the subarachnoid (SA) space and 19 in the ventricular system (IV). A questionnaire designed to assess exposure to classic NC risk factors 5, 10, 15, 20 and more than 20 years prior to diagnosis was applied. The results were compared between the three groups. Also, asymptomatic relatives of patients who had shared their living conditions in childhood or more recently were included and underwent brain scan and blood testing for specific antibodies.
Results
Over the course of their lives, exposure to risk factors decreased significantly for all patients, although the decrease was more evident in patients with parasites in the SA space ( p < 0.001) compared to patients with PAR ( p = 0.011) or IV cysts ( p = 0.020). Five years prior to diagnosis, exposure to risk factors was significantly higher in patients with PAR or IV NC than in patients with SA NC ( p = 0.04). Furthermore, individuals in close contact with PAR or IV patients in the years preceding diagnosis were more likely to have asymptomatic NC, specific antibodies in sera, particularly IgM, compared to individuals in close contact with SA patients during the same period.
Conclusions
All these findings are highly suggestive of the possibility of a more recent infection of patients affected by parenchymal and ventricular NC than of patients with subarachnoid NC. Consequently, subarachnoid disease could be considered a chronic disease, which, probably contributes to the severity of the disease as well as the minimal response to medical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clínica de neurocisticercosis, Instituto Nacional de Neurologia y Neurocirugía Manuel Velasco Suarez, Ciudad de México, Mexico.
- Departamento de Neurología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico.
- University of Bern, ISPM, Bern, Switzerland.
- Unidad de Neuro Inflamación, Departamento de Medicina Genómica y Toxicología ambiental, Instituto de Investigación Biomédicas, UNAM/Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNN-MVS), Méxic…
ORCID-Profile: Agnès Fleury
Zitieren
APA
Tellez-Arellano, C. A., Kuschick-Fehér, J., Romero-Gonzalez, F. G., & Fleury, A. (2024). Neurocysticercosis: The duration of its preclinical phase relies on the parasite location. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.13964
Vancouver
Tellez-Arellano CA, Kuschick-Fehér J, Romero-Gonzalez FG, Fleury A. Neurocysticercosis: The duration of its preclinical phase relies on the parasite location. Tropical Medicine & International Health. 2024. doi:10.1111/tmi.13964
BibTeX
@article{TellezArellano2024,
author = {Tellez-Arellano, Carlos Alejandro and Kuschick-Fehér, Jan and Romero-Gonzalez, Franco Gabriel and Fleury, Agnès},
title = {Neurocysticercosis: The duration of its preclinical phase relies on the parasite location},
journal = {Tropical Medicine & International Health},
year = {2024},
doi = {10.1111/tmi.13964}
}
EUVIMED